Inventor · disambiguated record
Khadijah M. Al-Zaydi
Also filed as: AL-ZAYDI KHADIJAH M · AL-ZAYDI KHADIJAH MOHAMED · AL-ZAYDI KHADIJAH MOHAMED KHALF
9 granted patents·6 citations·filing 2009–2022
78Inventor score
Top patents by PatentIndex Score
9 records- 0187US10975102B1Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agentsUNIV KING ABDULAZIZ·Filed 2020·Granted Apr 13, 2021·2 cites·4 claims
- 0286US11192902B1Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agentsUNIV KING ABDULAZIZ·Filed 2020·Granted Dec 7, 2021·2 cites·5 claims
- 0385US11104692B1Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agentsUNIV KING ABDULAZIZ·Filed 2021·Granted Aug 31, 2021·2 cites·4 claims
- 0454US11786537B2Therapeutic inhibition affinity of copper (II) complex and their diazenyl pyridinone heterocyclic ligands against SARS-CoV2UNIV KING ABDULAZIZ·Filed 2022·Granted Oct 17, 2023·0 cites·10 claims
- 0554US11492362B1Pyridine derivatives for the treatment of hyperproliferative diseasesUNIV KING ABDULAZIZ·Filed 2022·Granted Nov 8, 2022·0 cites·6 claims
- 0654US10981872B1Di(2-aryl hydrozonopropanal) arene derivativesUNIV KING ABDULAZIZ·Filed 2020·Granted Apr 20, 2021·0 cites·10 claims
- 0745US8278477B2Method for making a phosphorus ylideAL-ZAYDI KHADIJAH M·Filed 2009·Granted Oct 2, 2012·0 cites·5 claims
- 0843US10280134B1Potent cytotoxic agent against human hepatocellular carcinoma cell line based on 2-aryl hydrazonopropanal pharmacophoreUNIV KING ABDULAZIZ·Filed 2018·Granted May 7, 2019·0 cites·17 claims
- 0932US10266510B2Antimicrobial and cytotoxic compounds and methods for treating cancer, a bacterial infection, and/or a fungal infectionUNIV KING ABDULAZIZ·Filed 2017·Granted Apr 23, 2019·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Khadijah M. Al-Zaydi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →